Determining the Preliminary Efficacy of the Emergency Department Delirium Screening and Detection Program
Launched by NORTHWELL HEALTH · Dec 2, 2022
Trial Information
Current as of February 05, 2025
Completed
Keywords
ClinConnect Summary
Every three months, with the exception of when a site is in their implementation period, trained study staff members will conduct retrospective in-depth chart reviews on 250 randomly selected eligible patient visits per ED site. These chart reviews will assess presence of delirium as well as any corresponding delirium documentation, including the brief confusion assessment method (bCAM) and delirium mitigation and management strategies employed during the patient's ED visit. Charts will be pulled based on dates the participating site is within their control or intervention period (no chart ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Presenting to a participating study site emergency department (ED) during control or intervention periods
- • Survival to ED discharge or to hospital admission
- Exclusion Criteria:
- • Presenting to a participating study site ED during ED-DDP implementation periods
Trial Officials
Liron Sinvani, MD
Principal Investigator
Northwell Health
About Northwell Health
Northwell Health is a leading integrated health system based in New York, dedicated to advancing healthcare through innovative research and clinical trials. With a commitment to improving patient outcomes and enhancing medical knowledge, Northwell Health conducts a diverse range of clinical studies across various therapeutic areas. The organization harnesses its extensive network of hospitals, outpatient facilities, and research institutes to facilitate cutting-edge research, ensuring access to advanced treatments for patients while fostering collaboration among healthcare professionals, researchers, and industry partners. By prioritizing patient-centric approaches and leveraging state-of-the-art technology, Northwell Health aims to drive significant advancements in medical science and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Manhasset, New York, United States
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials